Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Iscience|June 24, 2019
Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in MelanomaRadoslav Janostiak, Parmanand Malvi, Narendra WajapeyeeTrends in Cancer|November 9, 2016
Oncogene-directed alterations in cancer cell metabolismArvindhan Nagarajan, Parmanand Malvi, Narendra WajapeyeeFrontiers in Endocrinology|September 11, 2018
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and ProgressionArvindhan Nagarajan, Parmanand Malvi, Narendra WajapeyeeJournal for Immunotherapy of Cancer|September 3, 2025
m<sup>6</sup>A-driven transcriptomic rewiring in tumor immune surveillanceParmanand Malvi, Patrick Ball, Romi Gupta, et al.Oncotarget|June 21, 2019
Dissecting the role of RNA modification regulatory proteins in melanomaParmanand Malvi, Biao Wang, Shreni Shah, et al.Iscience|August 9, 2022
Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growthSuresh Chava, Suresh Bugide, Parmanand Malvi, et al.Frontiers in Oncology|August 19, 2022
Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor-resistant pancreatic ductal adenocarcinomaParmanand Malvi, Vipin Rawat, Romi Gupta, et al.Molecular Metabolism|March 26, 2021
N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS productionParmanand Malvi, Radoslav Janostiak, Arvindhan Nagarajan, et al.Plos Genetics|October 8, 2019
Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expressionParmanand Malvi, Radoslav Janostiak, Arvindhan Nagarajan, et al.Iscience|May 14, 2024
ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical modelsSuresh Bugide, Dhana Sekhar Reddy, Parmanand Malvi, et al.Pageof 3